TY - JOUR
T1 - Early chronic obstructive pulmonary disease
T2 - Associations of two spirometry criteria with clinical features
AU - Mochizuki, Fumi
AU - Tanabe, Naoya
AU - Iijima, Hiroaki
AU - Shimada, Takafumi
AU - Shiraishi, Yusuke
AU - Maetani, Tomoki
AU - Yamazaki, Hajime
AU - Shimizu, Kaoruko
AU - Suzuki, Masaru
AU - Chubachi, Shotaro
AU - Ishikawa, Hiroichi
AU - Naito, Takashi
AU - Masuko, Hironori
AU - Sakamoto, Tohru
AU - Masuda, Izuru
AU - Sato, Susumu
AU - Hizawa, Nobuyuki
AU - Hirai, Toyohiro
N1 - Funding Information:
The authors thank Masanori Yasuda and Keiko Mitsuhata at Tsukuba Medical Center Hospital for their assistance in collecting the data. This study was partially supported by a grant from FUJIFILM Co., Ltd., Japan. None of the company had a role in the design or analysis of the study or in the writing of the manuscript.
Funding Information:
The authors thank Masanori Yasuda and Keiko Mitsuhata at Tsukuba Medical Center Hospital for their assistance in collecting the data. This study was partially supported by a grant from FUJIFILM Co. Ltd. Japan. None of the company had a role in the design or analysis of the study or in the writing of the manuscript.
Publisher Copyright:
© 2022 Elsevier Ltd
PY - 2022/11/1
Y1 - 2022/11/1
N2 - Background: Two spirometry criteria have been proposed for early chronic obstructive pulmonary disease (COPD) in young smokers: 1) forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) < the lower limit of normal (LLN), and 2) FEV1 decline ≥60 ml/year. These criteria have yet to be validated. This study explored clinical factors associated with these two spirometry criteria. Methods: This retrospective study analysed medical check-up data from 13,010 consecutive subjects aged <50 years who underwent current and 3 previous spirometry tests in Japan. Current ≥10 pack-year smokers were the main focus of analysis; those meeting one or more spirometry criteria were diagnosed with early COPD. Early COPD was categorized into three subtypes: FEV1/FVC < LLN and FEV1 decline <60 ml/year (type 1), FEV1/FVC ≥ LLN and FEV1 decline ≥60 ml/year (type 2), and FEV1/FVC < LLN and FEV1 decline ≥60 ml/year (type 3). Results: Of the 1579 current ≥ 10 pack-year smokers, 488 (30.9%) met the early COPD criteria. Multivariate multinomial logistic models adjusted for age, sex, height, body mass index (BMI) and smoking history indicated that past BMI increase and low exercise were associated with higher type 2 early COPD incidence (odds ratio (OR) [95% confidence interval (CI)] = 4.30 [3.10, 6.04], and 0.80 [0.69, 0.93], respectively) but not with higher type 1 incidence. A history of asthma was associated with higher type 3 incidence (OR [95% CI] = 1.98 [1.18, 3.07]). Conclusions: The 3 types of spirometry-based early COPD have different clinical factors. Their trajectories should be explored in longitudinal studies.
AB - Background: Two spirometry criteria have been proposed for early chronic obstructive pulmonary disease (COPD) in young smokers: 1) forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) < the lower limit of normal (LLN), and 2) FEV1 decline ≥60 ml/year. These criteria have yet to be validated. This study explored clinical factors associated with these two spirometry criteria. Methods: This retrospective study analysed medical check-up data from 13,010 consecutive subjects aged <50 years who underwent current and 3 previous spirometry tests in Japan. Current ≥10 pack-year smokers were the main focus of analysis; those meeting one or more spirometry criteria were diagnosed with early COPD. Early COPD was categorized into three subtypes: FEV1/FVC < LLN and FEV1 decline <60 ml/year (type 1), FEV1/FVC ≥ LLN and FEV1 decline ≥60 ml/year (type 2), and FEV1/FVC < LLN and FEV1 decline ≥60 ml/year (type 3). Results: Of the 1579 current ≥ 10 pack-year smokers, 488 (30.9%) met the early COPD criteria. Multivariate multinomial logistic models adjusted for age, sex, height, body mass index (BMI) and smoking history indicated that past BMI increase and low exercise were associated with higher type 2 early COPD incidence (odds ratio (OR) [95% confidence interval (CI)] = 4.30 [3.10, 6.04], and 0.80 [0.69, 0.93], respectively) but not with higher type 1 incidence. A history of asthma was associated with higher type 3 incidence (OR [95% CI] = 1.98 [1.18, 3.07]). Conclusions: The 3 types of spirometry-based early COPD have different clinical factors. Their trajectories should be explored in longitudinal studies.
KW - Asthma
KW - Body mass index
KW - Chronic obstructive pulmonary disease
KW - Early COPD
KW - Prevalence
UR - http://www.scopus.com/inward/record.url?scp=85140251463&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85140251463&partnerID=8YFLogxK
U2 - 10.1016/j.rmed.2022.107011
DO - 10.1016/j.rmed.2022.107011
M3 - Article
C2 - 36270155
AN - SCOPUS:85140251463
SN - 0954-6111
VL - 204
JO - Respiratory Medicine
JF - Respiratory Medicine
M1 - 107011
ER -